Progress Towards a National Cardiac Procedure Database—Development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) Registries

Williams, 2000, Percutaneous coronary intervention in the current era compared with 1985–1986: the National Heart, Lung, and Blood Institute Registries, Circulation, 102, 2945, 10.1161/01.CIR.102.24.2945 Dziuban, 1994, How a New York cardiac surgery program uses outcomes data, Ann Thorac Surg, 58, 1871, 10.1016/0003-4975(94)91730-2 Hannan, 1992, Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes, JAMA, 268, 3092, 10.1001/jama.1992.03490210074038 Ferguson, 2000, The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons, Ann Thorac Surg, 69, 680, 10.1016/S0003-4975(99)01538-6 Chew, 2007, Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit, Intern Med J, 37, 741 MacMahon, 2001, Reliable assessment of the effects of treatment on mortality and major morbidity. II: observational studies, Lancet, 357, 455, 10.1016/S0140-6736(00)04017-4 Australian Institute of Health and Welfare (AIHW), 2004 Australian Institute of Health and Welfare (AIHW), 2008 Dinh, 2008, Trends in coronary artery bypass graft surgery in Victoria, 2001–2006: findings from the Australasian Society of Cardiac and Thoracic Surgeons database project, Med J Aust, 188, 214, 10.5694/j.1326-5377.2008.tb01587.x Rosenfeldt, 2001, National cardiac databases for Australia, Heart Lung Circ, 10, 1, 10.1046/j.1444-2892.2001.00058.x Moses, 2003, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med, 349, 1315, 10.1056/NEJMoa035071 Stone, 2004, A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease, N Engl J Med, 350, 221, 10.1056/NEJMoa032441 Lagerqvist, 2007, Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden, N Engl J Med, 356, 1009, 10.1056/NEJMoa067722 Pfisterer, 2006, Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents, J Am Coll Cardiol, 48, 2584, 10.1016/j.jacc.2006.10.026 Iakovou, 2005, Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA, 293, 2126, 10.1001/jama.293.17.2126 Butler, 2009, The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents, Am Heart J, 157, 899, 10.1016/j.ahj.2009.02.018 Tu, 2007, Effectiveness and safety of drug-eluting stents in Ontario, N Engl J Med, 357, 1393, 10.1056/NEJMoa071076 James, 2009, Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden, N Engl J Med, 360, 1933, 10.1056/NEJMoa0809902 Tonkin, 2001, Why Australia needs a Cardiac Procedures Database, Heart Lung Circ, 10, S22, 10.1046/j.1444-2892.2001.00071.x Davies, 2003 Chew, 2005, National data elements for the clinical management of acute coronary syndromes, Med J Aust, 182, S1 Cannon, 2001, J Am Coll Cardiol, 38, 2114, 10.1016/S0735-1097(01)01702-8 Scott, 2008, Why we need a national registry in interventional cardiology, Med J Aust, 189, 223, 10.5694/j.1326-5377.2008.tb01989.x Fine, 2003, How to evaluate and improve the quality and credibility of an outcomes database: validation and feedback study on the UK Cardiac Surgery Experience, BMJ, 326, 25, 10.1136/bmj.326.7379.25 Wyse, 1999, The development of an international surgical registry: the ECSUR project. The European Cardiac Surgical Registry, Eur J Cardiothorac Surg, 16, 2, 10.1016/S1010-7940(99)00129-3 Welke, 2004, Validity of the society of thoracic surgeons national adult cardiac surgery database, Ann Thorac Surg, 77, 1137, 10.1016/j.athoracsur.2003.07.030 Detre, 1988, Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981. The National Heart, Lung, and Blood Institute Registry, N Engl J Med, 318, 265, 10.1056/NEJM198802043180501 Hannan, 1997, Coronary angioplasty volume-outcome relationships for hospitals and cardiologists, JAMA, 277, 892, 10.1001/jama.1997.03540350042031 Hannan, 1999, A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty, J Am Coll Cardiol, 33, 63, 10.1016/S0735-1097(98)00540-3 Apolito, 2008, Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock, Am Heart J, 155, 267, 10.1016/j.ahj.2007.10.013 Topol, 1994, Scorecard cardiovascular medicine. Its impact and future directions, Ann Intern Med, 120, 65, 10.7326/0003-4819-120-1-199401010-00011 Chassin, 1996, Benefits and hazards of reporting medical outcomes publicly, N Engl J Med, 334, 394, 10.1056/NEJM199602083340611 Reid, 2001, Developing performance indicators for cardiac surgery: a demonstration project in Victoria, Heart Lung Circ, 10, S29, 10.1046/j.1444-2892.2001.00073.x Ajani, 2006, The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project, Heart Lung Circ, 15, 44, 10.1016/j.hlc.2005.08.001 Anderson, 2002, A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR), J Am Coll Cardiol, 39, 1096, 10.1016/S0735-1097(02)01733-3 Shaw, 2002, Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998–2000, J Am Coll Cardiol, 39, 1104, 10.1016/S0735-1097(02)01731-X Dyke, 2000, National and regional registries: what good are they?, Eur Heart J, 21, 1401, 10.1053/euhj.2000.2304 Reid, 2004, Initial twelve months experience and analysis for 2001–2002 from the Australasian Society of Cardiac and Thoracic Surgeons—Victorian database project, Heart Lung Circ, 13, 291, 10.1016/j.hlc.2004.05.006 Welke, 2007, Comparison of cardiac surgery volumes and mortality rates between the Society of Thoracic Surgeons and Medicare databases from 1993 through 2001, Ann Thorac Surg, 84, 1538, 10.1016/j.athoracsur.2007.06.022 Bridgewater, 1998, Predicting operative risk for coronary artery surgery in the United Kingdom: a comparison of various risk prediction algorithms, Heart, 79, 350, 10.1136/hrt.79.4.350 Silber, 2005, Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology, Eur Heart J, 26, 804, 10.1093/eurheartj/ehi138 AIHW, 2004 Myers, 1999, CASS Registry long term surgical survival. Coronary Artery Surgery Study, J Am Coll Cardiol, 33, 488, 10.1016/S0735-1097(98)00563-4 Rankin, 1999, Improved clinical outcome after widespread use of coronary-artery stenting in Canada, N Engl J Med, 341, 1957, 10.1056/NEJM199912233412602 Yap, 2009, Short- and midterm outcomes of coronary artery bypass surgery performed by surgeons in training, J Thorac Cardiovasc Surg, 137, 1088, 10.1016/j.jtcvs.2008.10.011 Yap, 2006, Validation of the EuroSCORE model in Australia, Eur J Cardiothorac Surg, 29, 441, 10.1016/j.ejcts.2005.12.046 Reid, 2007, The AusSCORE—a validated model for predicting outcome following isolated coronary bypass graft procedures in Australia, Heart Lung Circ, 16, S179, 10.1016/j.hlc.2007.06.447 Reid, 2009, An Australian risk prediction model for 30-day mortality after isolated coronary artery bypass: the AusSCORE, J Thorac Cardiovasc Surg, 138, 904, 10.1016/j.jtcvs.2009.03.020 Wu, 2006, A risk score to predict in-hospital mortality for percutaneous coronary interventions, J Am Coll Cardiol, 47, 654, 10.1016/j.jacc.2005.09.071 Serruys, 2009, Assessment of the SYNTAX score in the Syntax study, Eurointervention, 5, 50, 10.4244/EIJV5I1A9 van Hout, 2005, One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial, Heart, 91, 507, 10.1136/hrt.2004.034454 Baim, 2006, Postmarket surveillance for drug-eluting coronary stents: a comprehensive approach, Circulation, 113, 891, 10.1161/CIRCULATIONAHA.105.569657 Ward, 2005, Cost-benefit of drug eluting stents-time for a reality check, Heart Lung Circ, 14, 74, 10.1016/j.hlc.2005.03.005 Kaiser, 2005, Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET), Lancet, 366, 921, 10.1016/S0140-6736(05)67221-2 Lord, 2005, A systematic review and economic analysis of drug-eluting coronary stents available in Australia, Med J Aust, 183, 464, 10.5694/j.1326-5377.2005.tb07124.x Ajani, 2008, Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry, Med J Aust, 189, 423, 10.5694/j.1326-5377.2008.tb02113.x Yan, 2008, Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian Multicenter Registry), Am J Cardiol, 101, 1716, 10.1016/j.amjcard.2008.02.058 Narins, 2005, The influence of public reporting of outcome data on medical decision making by physicians, Arch Intern Med, 165, 83, 10.1001/archinte.165.1.83 NHMRC Centre for Research Excellence in Patient Safety MU, (NEHTA) NE-HTA, 2008